AstraZeneca

AstraZeneca Rises After FDA Approval of Brilinta Blood-Thinner
Bloomberg
Thu, 07/21/11 - 10:55 am
blood thinners
Brilinta
FDA
AstraZeneca
AstraZeneca Wins U.S. Approval for Blood Thinner Brilinta to Rival Plavix
Bloomberg
Wed, 07/20/11 - 06:46 pm
Plavix
blood thinners
AstraZeneca
Sanofi
Bristol-Myers Squibb
Brilinta
Bristol, AstraZeneca Rebuffed by FDA Panel on Diabetes Drug
Bloomberg
Tue, 07/19/11 - 06:11 pm
FDA
AstraZeneca
diabetes
Bristol-Myers Squibb
Dapagliflozin
Regulatory "sword of Damocles" dangles over two big AZ drugs
Fierce Biotech
Tue, 07/19/11 - 01:14 pm
AstraZeneca
FDA
Brilinta
blood thinners
Dapagliflozin
Bristol-Myers Squibb
FDA pushes new heart warning on AZ's Seroquel
Fierce Pharma
Tue, 07/19/11 - 12:19 pm
AstraZeneca
Seroquel
FDA
warnings
antipsychotics
Eli Lilly: Poised to Reward Patient Investors?
Seeking Alpha
Tue, 07/19/11 - 10:15 am
Eli Lilly
investors
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Forest Labs
Impax
Mylan
Teva Pharmaceuticals
Watson Pharmaceuticals
FDA Cites Risks in Diabetes Drug
Motley Fool
Sun, 07/17/11 - 12:04 pm
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
High Yield Large-Cap Pharma: Recent Performance and 5-Year Dividend Growth Analysis
Seeking Alpha
Sat, 07/16/11 - 11:45 am
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GSK
Merck
Pfizer
Sanofi
FDA Says Bristol-AstraZeneca Diabetes Drug May Cause Cancer
Bloomberg
Fri, 07/15/11 - 02:21 pm
FDA
diabetes
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
bladder cancer
AstraZeneca unit loses patent rights
FT.com
Wed, 07/6/11 - 08:17 am
AstraZeneca
patents
Roche
MedImmune
ranibizumab
Novartis
Eli Lilly Reaffirms Commitment to Innovation but Needs to Deliver
Seeking Alpha
Tue, 07/5/11 - 04:37 pm
innovation
Eli Lilly
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
Par Restructures Branded Business
Yahoo/Zacks.com
Tue, 07/5/11 - 10:56 am
Par Pharmaceutical
reorganization
AstraZeneca
July Catalysts for Biotech and Drug Stocks
Minyanville
Tue, 07/5/11 - 09:58 am
Seattle Genetics
Bristol-Myers Squibb
JNJ
advisory panels
FDA
Transcept
AstraZeneca
GSK
Human Genome Sciences
Merck
Theravance
Amgen
Biogen Idec
Acorda Therapeutics
Dentsply Acquisition Delivers Smiles
Motley Fool
Mon, 07/4/11 - 09:11 am
M&A
Dentsply
AstraZeneca
dental
Astra Tech
3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review
Motley Fool
Fri, 07/1/11 - 09:44 am
FDA
Bristol-Myers Squibb
AstraZeneca
Pfizer
Incyte
Novartis
ruxolitinib
Apixaban
Dapagliflozin
6 Healthcare Companies With July Catalysts
Seeking Alpha
Thu, 06/30/11 - 07:26 pm
Alexa
AstraZeneca
Bristol-Myers Squibb
JNJ
Seattle Genetics
Transcept
Study points to possible aspirin link with Astra heart drug
Reuters
Tue, 06/28/11 - 11:38 pm
AstraZeneca
Brilinta
aspirin
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Bloomberg
Mon, 06/27/11 - 05:53 pm
Brilinta
AstraZeneca
aspirin
Plavix
Sanofi
Bristol-Myers Squibb
Life Technologies Ties Up with Pharma Majors
Yahoo/Zacks.com
Mon, 06/27/11 - 10:36 am
Life Technologies
AstraZeneca
Illumina
JNJ
Bristol-Myers, AstraZeneca Diabetes Drug Shows Bladder, Breast Cancer Risk
Bloomberg
Sun, 06/26/11 - 12:09 pm
Bristol-Myers Squibb
AstraZeneca
Dapagliflozin
diabetes

Pages